Remote digital monitoring of medication intake: methodological, medical, ethical and legal reflections
Authors:
- 23 December 2019
- journal article
- research article
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 76 (3) , 209-216
Abstract
In 2017, regulatory approval was given in the US for a ‘digital pill’, a pill for which actual ingestion could be remotely monitored. The pill, Abilify Mycite is marketed by Otsuka but the monitoring system derives from Proteus Digital Health. In this paper, we focus on this digital pill and another equivalent system from AiCure which relies on facial recognition. Both systems not only remind the patient to take a pill but also verify the actual intake. In this process, patient-related data beyond the fact that the pill has been taken are also collected and sent to a remote computer system of the system-providing company and possibly to third parties. Although marketed as ‘innovative’, the introduction of such systems raises questions as to the limitation of patient autonomy, secondary uses of patient data, impact on the physician’s liability, and artificial inflation of drug prices. Whereas incorrect medication taking can be problematic, it can be questioned whether remote intake-monitoring systems are, from an ethical, legal and social perspective, the ideal way to address this. In this paper, we will reflect on this question from the position of the different potential stakeholders involved.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (FWO.OPR.2019.0045.01)
- H2020 Marie Skłodowska-Curie Actions (DLV-794604)
This publication has 21 references indexed in Scilit:
- In Search of a “Magic Pill” for Medication NonadherenceJAMA Internal Medicine, 2017
- Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With SchizophreniaJMIR mHealth and uHealth, 2017
- What’s in a name? Compliance, adherence and concordance in chronic psychiatric disordersWorld Journal of Psychiatry, 2014
- European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelinesNephrology Dialysis Transplantation, 2013
- Medication NonadherenceJAMA, 2013
- Rethinking AdherenceAnnals of Internal Medicine, 2012
- Treatment adherence redefined: a critical analysis of technotherapeuticsNursing Inquiry, 2012
- Factors That Can Affect the External Validity of Randomised Controlled TrialsPLoS Clinical Trials, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 casesThe American Journal of Medicine, 2001